Literature DB >> 10587190

Edema volume, not timing, is the key to success in lymphedema treatment.

S M Ramos1, L S O'Donnell, G Knight.   

Abstract

BACKGROUND: There are currently between 1 and 2 million breast cancer survivors in the United States. Is the advocated, early intervention the key to successful treatment, or are there other, more important factors?
METHODS: Responses to combined decongestive therapy (CDT) for 69 women were analyzed with regard to duration of lymphedema, differences in arm circumference, percent differences in arm volumes, volume of edema, reduction of edema volumes, and duration of treatment.
RESULTS: Two- and three-dimensional (2D and 3D) analyses showed little correlation between duration and volume of edema or between duration and response and treatment. However, they did show a correlation between initial volumes of fluid in the tissues and responses. Patients with initial volumes of 250 mL or less had a mean reduction of 78% with CDT, whereas those with initial volumes between 250 and 500 mL had a mean reduction of 56%.
CONCLUSION: The key to predicting successful lymphedema treatment is the initial volume of edema in the tissues regardless of whether the intervention is early or late.

Entities:  

Mesh:

Year:  1999        PMID: 10587190     DOI: 10.1016/s0002-9610(99)00185-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  21 in total

Review 1.  Manual lymphatic drainage for lymphedema following breast cancer treatment.

Authors:  Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak
Journal:  Cochrane Database Syst Rev       Date:  2015-05-21

2.  A pilot randomized trial evaluating low-level laser therapy as an alternative treatment to manual lymphatic drainage for breast cancer-related lymphedema.

Authors:  Sheila H Ridner; Ellen Poage-Hooper; Collin Kanar; Jennifer K Doersam; Stewart M Bond; Mary S Dietrich
Journal:  Oncol Nurs Forum       Date:  2013-07       Impact factor: 2.172

3.  Lymphoedema and health-related quality of life by early treatment in long-term survivors of breast cancer. A comparative retrospective study up to 15 years after diagnosis.

Authors:  Katarina Y Karlsson; Imke Wallenius; Lena B Nilsson-Wikmar; Henrik Lindman; Birgitta B K Johansson
Journal:  Support Care Cancer       Date:  2015-03-06       Impact factor: 3.603

4.  Segmental measurement of breast cancer-related arm lymphoedema using perometry and bioimpedance spectroscopy.

Authors:  Sharon A Czerniec; Leigh C Ward; Mi-Joung Lee; Kathryn M Refshauge; Jane Beith; Sharon L Kilbreath
Journal:  Support Care Cancer       Date:  2010-05-15       Impact factor: 3.603

5.  A pilot randomized trial evaluating lymphedema self-measurement with bioelectrical impedance, self-care adherence, and health outcomes.

Authors:  Sheila H Ridner; Ya-Chen Tina Shih; Jennifer K Doersam; Bethany Andrews Rhoten; Benjamin S Schultze; Mary S Dietrich
Journal:  Lymphat Res Biol       Date:  2014-12       Impact factor: 2.589

6.  Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study.

Authors:  Dorit Tidhar; Michal Katz-Leurer
Journal:  Support Care Cancer       Date:  2009-06-03       Impact factor: 3.603

7.  Diagnosis and treatment of lymphedema after breast cancer: a population-based study.

Authors:  Oksana Sayko; Liliana E Pezzin; Tina W F Yen; Ann B Nattinger
Journal:  PM R       Date:  2013-05-17       Impact factor: 2.298

8.  Communicating vessels volumeter to measure upper extremity lymphedema after breast cancer: reliability and criterion validity compared to the gold standard.

Authors:  Rogério Mendonça de Carvalho; Fausto Miranda
Journal:  Braz J Phys Ther       Date:  2018-11-12       Impact factor: 3.377

Review 9.  The treatment of lymphedema related to breast cancer: a systematic review and evidence summary.

Authors:  Lyn Kligman; Rebecca K S Wong; Mary Johnston; Nancy S Laetsch
Journal:  Support Care Cancer       Date:  2004-04-17       Impact factor: 3.603

10.  The results of the intensive phase of complete decongestive therapy and the determination of predictive factors for response to treatment in patients with breast cancer related-lymphedema.

Authors:  Dilek Keskin; Meltem Dalyan; Sibel Ünsal-Delialioğlu; Ülkü Düzlü-Öztürk
Journal:  Cancer Rep (Hoboken)       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.